Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 172

1.

Hospital-level high-risk antibiotic use in relation to hospital-associated Clostridioides difficile infections: Retrospective analysis of 2016-2017 data from US hospitals.

Tabak YP, Srinivasan A, Yu KC, Kurtz SG, Gupta V, Gelone S, Scoble PJ, McDonald LC.

Infect Control Hosp Epidemiol. 2019 Sep 16:1-7. doi: 10.1017/ice.2019.236. [Epub ahead of print]

PMID:
31522695
2.

A national survey of testing and management of asymptomatic carriage of C. difficile.

Kutty PK, Beekmann SE, Sinkowitz-Cochran RL, Dubberke ER, Kuhar DT, McDonald LC, Polgreen PM.

Infect Control Hosp Epidemiol. 2019 Jul;40(7):801-803. doi: 10.1017/ice.2019.109. Epub 2019 May 20.

PMID:
31106723
3.

Risk factors for community-associated Clostridioides difficile infection in young children.

Weng MK, Adkins SH, Bamberg W, Farley MM, Espinosa CC, Wilson L, Perlmutter R, Holzbauer S, Whitten T, Phipps EC, Hancock EB, Dumyati G, Nelson DS, Beldavs ZG, Ocampo V, Davis CM, Rue B, Korhonen L, McDonald LC, Guh AY.

Epidemiol Infect. 2019 Jan;147:e172. doi: 10.1017/S0950268819000372.

4.

Vital Signs: Epidemiology and Recent Trends in Methicillin-Resistant and in Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections - United States.

Kourtis AP, Hatfield K, Baggs J, Mu Y, See I, Epson E, Nadle J, Kainer MA, Dumyati G, Petit S, Ray SM; Emerging Infections Program MRSA author group, Ham D, Capers C, Ewing H, Coffin N, McDonald LC, Jernigan J, Cardo D.

MMWR Morb Mortal Wkly Rep. 2019 Mar 8;68(9):214-219. doi: 10.15585/mmwr.mm6809e1.

5.

Association between Antibiotic Use and Hospital-Onset Clostridioidesdifficile Infection in U.S. Acute Care Hospitals, 2006-2012: an Ecologic Analysis.

Kazakova SV, Baggs J, McDonald LC, Yi SH, Hatfield KM, Guh A, Reddy SC, Jernigan JA.

Clin Infect Dis. 2019 Mar 1. pii: ciz169. doi: 10.1093/cid/ciz169. [Epub ahead of print]

PMID:
30820545
6.

Assessing the social cost and benefits of a national requirement establishing antibiotic stewardship programs to prevent Clostridioides difficile infection in US hospitals.

Scott RD 2nd, Slayton RB, Lessa FC, Baggs J, Culler SD, McDonald LC, Jernigan JA.

Antimicrob Resist Infect Control. 2019 Jan 22;8:17. doi: 10.1186/s13756-018-0459-1. eCollection 2019.

7.

Toxin Enzyme Immunoassays Detect Clostridioides difficile Infection with Greater Severity and Higher Recurrence Rates.

Guh AY, Hatfield KM, Winston LG, Martin B, Johnston H, Brousseau G, Farley MM, Wilson L, Perlmutter R, Phipps EC, Dumyati GK, Nelson D, Hatwar T, Kainer MA, Paulick AL, Karlsson M, Gerding DN, McDonald LC.

Clin Infect Dis. 2019 Jan 7. doi: 10.1093/cid/ciz009. [Epub ahead of print]

PMID:
30615074
8.

Reply to Fabre et al.

McDonald LC, Johnson S, Bakken JS, Garey KW, Kelly C, Gerding DN.

Clin Infect Dis. 2018 Nov 28;67(12):1958-1959. doi: 10.1093/cid/ciy475. No abstract available.

PMID:
29860268
9.

Transmission of Clostridium difficile from asymptomatically colonized or infected long-term care facility residents.

Donskey CJ, Sunkesula VCK, Stone ND, Gould CV, McDonald LC, Samore M, Mayer J, Pacheco SM, Jencson AL, Sambol SP, Petrella LA, Gulvik CA, Gerding DN.

Infect Control Hosp Epidemiol. 2018 Aug;39(8):909-916. doi: 10.1017/ice.2018.106. Epub 2018 May 31.

PMID:
29848392
10.

The Challenges of Tracking Clostridium difficile to Its Source in Hospitalized Patients.

O'Hagan JJ, McDonald LC.

Clin Infect Dis. 2019 Jan 7;68(2):210-212. doi: 10.1093/cid/ciy461. No abstract available.

PMID:
29846537
11.

Point-Counterpoint: Active Surveillance for Carriers of Toxigenic Clostridium difficile Should Be Performed To Guide Prevention Efforts.

McDonald LC, Diekema DJ.

J Clin Microbiol. 2018 Jul 26;56(8). pii: e00782-18. doi: 10.1128/JCM.00782-18. Print 2018 Aug.

12.

Risk Factors for Community-Associated Clostridium difficile Infection in Adults: A Case-Control Study.

Guh AY, Adkins SH, Li Q, Bulens SN, Farley MM, Smith Z, Holzbauer SM, Whitten T, Phipps EC, Hancock EB, Dumyati G, Concannon C, Kainer MA, Rue B, Lyons C, Olson DM, Wilson L, Perlmutter R, Winston LG, Parker E, Bamberg W, Beldavs ZG, Ocampo V, Karlsson M, Gerding DN, McDonald LC.

Open Forum Infect Dis. 2017 Oct 26;4(4):ofx171. doi: 10.1093/ofid/ofx171. eCollection 2017 Fall.

13.

Vital Signs: Containment of Novel Multidrug-Resistant Organisms and Resistance Mechanisms - United States, 2006-2017.

Woodworth KR, Walters MS, Weiner LM, Edwards J, Brown AC, Huang JY, Malik S, Slayton RB, Paul P, Capers C, Kainer MA, Wilde N, Shugart A, Mahon G, Kallen AJ, Patel J, McDonald LC, Srinivasan A, Craig M, Cardo DM.

MMWR Morb Mortal Wkly Rep. 2018 Apr 6;67(13):396-401. doi: 10.15585/mmwr.mm6713e1.

14.

Reply to Collins and Riley.

McDonald LC, Gerding DN, Johnson S.

Clin Infect Dis. 2018 Oct 30;67(10):1640. doi: 10.1093/cid/ciy251. No abstract available.

PMID:
29590312
15.

Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA).

McDonald LC, Gerding DN, Johnson S, Bakken JS, Carroll KC, Coffin SE, Dubberke ER, Garey KW, Gould CV, Kelly C, Loo V, Shaklee Sammons J, Sandora TJ, Wilcox MH.

Clin Infect Dis. 2018 Mar 19;66(7):987-994. doi: 10.1093/cid/ciy149.

PMID:
29562266
16.

Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA).

McDonald LC, Gerding DN, Johnson S, Bakken JS, Carroll KC, Coffin SE, Dubberke ER, Garey KW, Gould CV, Kelly C, Loo V, Shaklee Sammons J, Sandora TJ, Wilcox MH.

Clin Infect Dis. 2018 Mar 19;66(7):e1-e48. doi: 10.1093/cid/cix1085.

17.

Risk of Subsequent Sepsis Within 90 Days After a Hospital Stay by Type of Antibiotic Exposure.

Baggs J, Jernigan JA, Halpin AL, Epstein L, Hatfield KM, McDonald LC.

Clin Infect Dis. 2018 Mar 19;66(7):1004-1012. doi: 10.1093/cid/cix947.

PMID:
29136126
18.

Intestinal Carriage of Third-Generation Cephalosporin-Resistant and Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Healthy US Children.

Islam S, Selvarangan R, Kanwar N, McHenry R, Chappell JD, Halasa N, Wikswo ME, Payne DC, Azimi PH, McDonald LC, Gomez-Duarte OG.

J Pediatric Infect Dis Soc. 2018 Aug 17;7(3):234-240. doi: 10.1093/jpids/pix045.

19.

Effects of short- and long-course antibiotics on the lower intestinal microbiome as they relate to traveller's diarrhea.

McDonald LC.

J Travel Med. 2017 Apr 1;24(suppl_1):S35-S38. doi: 10.1093/jtm/taw084. Review.

20.

Diagnosing an Infection Control Risk.

Kutty PK, McDonald LC.

Clin Infect Dis. 2017 May 1;64(9):1171-1173. doi: 10.1093/cid/cix085. No abstract available.

21.

Assessment of the Overall and Multidrug-Resistant Organism Bioburden on Environmental Surfaces in Healthcare Facilities.

Shams AM, Rose LJ, Edwards JR, Cali S, Harris AD, Jacob JT, LaFae A, Pineles LL, Thom KA, McDonald LC, Arduino MJ, Noble-Wang JA.

Infect Control Hosp Epidemiol. 2016 Dec;37(12):1426-1432. Epub 2016 Sep 13.

22.

Active Surveillance and Isolation of Asymptomatic Carriers of Clostridium difficile at Hospital Admission: Containing What Lies Under the Waterline.

Guh AY, McDonald LC.

JAMA Intern Med. 2016 Jun 1;176(6):805-6. doi: 10.1001/jamainternmed.2016.1118. No abstract available.

23.

Editorial Commentary: The Dawning of Microbiome Remediation for Addressing Antibiotic Resistance.

Halpin AL, McDonald LC.

Clin Infect Dis. 2016 Jun 15;62(12):1487-8. doi: 10.1093/cid/ciw187. Epub 2016 Mar 29. No abstract available.

24.

Vital Signs: Preventing Antibiotic-Resistant Infections in Hospitals - United States, 2014.

Weiner LM, Fridkin SK, Aponte-Torres Z, Avery L, Coffin N, Dudeck MA, Edwards JR, Jernigan JA, Konnor R, Soe MM, Peterson K, McDonald LC.

MMWR Morb Mortal Wkly Rep. 2016 Mar 11;65(9):235-41. doi: 10.15585/mmwr.mm6509e1.

25.

Letter in Response to "Questionable validity of the catheter-associated urinary tract infection metric used for value-based purchasing".

Halpin AL, Sinkowitz-Cochran R, Allen-Bridson K, Edwards JR, Pollock D, McDonald LC, Gould CV.

Am J Infect Control. 2016 Mar 1;44(3):369-70. doi: 10.1016/j.ajic.2015.11.035. No abstract available.

26.

Intestinal microbiome disruption in patients in a long-term acute care hospital: A case for development of microbiome disruption indices to improve infection prevention.

Halpin AL, de Man TJ, Kraft CS, Perry KA, Chan AW, Lieu S, Mikell J, Limbago BM, McDonald LC.

Am J Infect Control. 2016 Jul 1;44(7):830-6. doi: 10.1016/j.ajic.2016.01.003. Epub 2016 Feb 19.

27.

Prevalence of probiotic use among inpatients: A descriptive study of 145 U.S. hospitals.

Yi SH, Jernigan JA, McDonald LC.

Am J Infect Control. 2016 May 1;44(5):548-53. doi: 10.1016/j.ajic.2015.12.001. Epub 2016 Jan 25.

PMID:
26822808
28.

Burden of Nursing Home-Onset Clostridium difficile Infection in the United States: Estimates of Incidence and Patient Outcomes.

Hunter JC, Mu Y, Dumyati GK, Farley MM, Winston LG, Johnston HL, Meek JI, Perlmutter R, Holzbauer SM, Beldavs ZG, Phipps EC, Dunn JR, Cohen JA, Avillan J, Stone ND, Gerding DN, McDonald LC, Lessa FC.

Open Forum Infect Dis. 2016 Jan 18;3(1):ofv196. doi: 10.1093/ofid/ofv196. eCollection 2016 Jan.

29.

Diagnosis and Treatment of Clostridium difficile Infection (CDI).

Gerding DN, File TM Jr, McDonald LC.

Infect Dis Clin Pract (Baltim Md). 2016 Jan;24(1):3-10. doi: 10.1097/IPC.0000000000000350.

30.

Association Between Outpatient Antibiotic Prescribing Practices and Community-Associated Clostridium difficile Infection.

Dantes R, Mu Y, Hicks LA, Cohen J, Bamberg W, Beldavs ZG, Dumyati G, Farley MM, Holzbauer S, Meek J, Phipps E, Wilson L, Winston LG, McDonald LC, Lessa FC.

Open Forum Infect Dis. 2015 Aug 11;2(3):ofv113. doi: 10.1093/ofid/ofv113. eCollection 2015 Sep.

31.

A Potential Cellular Explanation for the Increased Risk of Clostridium difficile Infection Due to Hypoalbuminemia: Reply Di Bella et al.

Tabak YP, Johannes RS, McDonald LC.

Infect Control Hosp Epidemiol. 2015 Dec;36(12):1480. doi: 10.1017/ice.2015.235. Epub 2015 Oct 12. No abstract available.

32.

Identification of population at risk for future Clostridium difficile infection following hospital discharge to be targeted for vaccine trials.

Baggs J, Yousey-Hindes K, Ashley ED, Meek J, Dumyati G, Cohen J, Wise ME, McDonald LC, Lessa FC.

Vaccine. 2015 Nov 17;33(46):6241-9. doi: 10.1016/j.vaccine.2015.09.078. Epub 2015 Oct 9.

33.

Burden of Clostridium difficile infection in the United States.

Lessa FC, Winston LG, McDonald LC; Emerging Infections Program C. difficile Surveillance Team.

N Engl J Med. 2015 Jun 11;372(24):2369-70. doi: 10.1056/NEJMc1505190. No abstract available.

PMID:
26061850
34.

Causes, Burden, and Prevention of Clostridium difficile Infection.

Gould CV, File TM Jr, McDonald LC.

Infect Dis Clin Pract (Baltim Md). 2015 May;23(6):281-288. doi: 10.1097/IPC.0000000000000331.

35.

The cost-benefit of federal investment in preventing Clostridium difficile infections through the use of a multifaceted infection control and antimicrobial stewardship program.

Slayton RB, Scott RD, Baggs J, Lessa FC, McDonald LC, Jernigan JA.

Infect Control Hosp Epidemiol. 2015 Jun;36(6):681-7. doi: 10.1017/ice.2015.43. Epub 2015 Mar 18.

36.

Predicting the risk for hospital-onset Clostridium difficile infection (HO-CDI) at the time of inpatient admission: HO-CDI risk score.

Tabak YP, Johannes RS, Sun X, Nunez CM, McDonald LC.

Infect Control Hosp Epidemiol. 2015 Jun;36(6):695-701. doi: 10.1017/ice.2015.37. Epub 2015 Mar 10.

37.

Determinants of Clostridium difficile Infection Incidence Across Diverse United States Geographic Locations.

Lessa FC, Mu Y, Winston LG, Dumyati GK, Farley MM, Beldavs ZG, Kast K, Holzbauer SM, Meek JI, Cohen J, McDonald LC, Fridkin SK.

Open Forum Infect Dis. 2014 Jul 28;1(2):ofu048. doi: 10.1093/ofid/ofu048. eCollection 2014 Sep.

38.

Burden of Clostridium difficile infection in the United States.

Lessa FC, Mu Y, Bamberg WM, Beldavs ZG, Dumyati GK, Dunn JR, Farley MM, Holzbauer SM, Meek JI, Phipps EC, Wilson LE, Winston LG, Cohen JA, Limbago BM, Fridkin SK, Gerding DN, McDonald LC.

N Engl J Med. 2015 Feb 26;372(9):825-34. doi: 10.1056/NEJMoa1408913.

39.

Uncovering the role of antibiotics in the transmission of multidrug-resistant organisms.

McDonald LC.

JAMA Intern Med. 2015 Apr;175(4):633-4. doi: 10.1001/jamainternmed.2014.8279. No abstract available.

40.

Strategies to prevent Clostridium difficile infections in acute care hospitals: 2014 update.

Dubberke ER, Carling P, Carrico R, Donskey CJ, Loo VG, McDonald LC, Maragakis LL, Sandora TJ, Weber DJ, Yokoe DS, Gerding DN.

Infect Control Hosp Epidemiol. 2014 Sep;35 Suppl 2:S48-65. No abstract available.

PMID:
25376069
41.

CDC central-line bloodstream infection prevention efforts produced net benefits of at least $640 Million during 1990-2008.

Scott RD 2nd, Sinkowitz-Cochran R, Wise ME, Baggs J, Goates S, Solomon SL, McDonald LC, Jernigan JA.

Health Aff (Millwood). 2014 Jun;33(6):1040-7. doi: 10.1377/hlthaff.2013.0865.

PMID:
24889954
42.

Strategies to prevent Clostridium difficile infections in acute care hospitals: 2014 Update.

Dubberke ER, Carling P, Carrico R, Donskey CJ, Loo VG, McDonald LC, Maragakis LL, Sandora TJ, Weber DJ, Yokoe DS, Gerding DN.

Infect Control Hosp Epidemiol. 2014 Jun;35(6):628-45. doi: 10.1086/676023. No abstract available.

PMID:
24799639
43.

Clostridium difficile infection among children across diverse US geographic locations.

Wendt JM, Cohen JA, Mu Y, Dumyati GK, Dunn JR, Holzbauer SM, Winston LG, Johnston HL, Meek JI, Farley MM, Wilson LE, Phipps EC, Beldavs ZG, Gerding DN, McDonald LC, Gould CV, Lessa FC.

Pediatrics. 2014 Apr;133(4):651-8. doi: 10.1542/peds.2013-3049. Epub 2014 Mar 3.

PMID:
24590748
44.

Utility of a commercial PCR assay and a clinical prediction rule for detection of toxigenic Clostridium difficile in asymptomatic carriers.

Donskey CJ, Sunkesula VC, Jencson AL, Stone ND, Gould CV, McDonald LC, Samore M, Mayer J, Pacheco S, Sambol S, Petrella L, Terry D, Gerding DN.

J Clin Microbiol. 2014 Jan;52(1):315-8. doi: 10.1128/JCM.01852-13. Epub 2013 Oct 23.

45.

Effect of nucleic acid amplification testing on population-based incidence rates of Clostridium difficile infection.

Gould CV, Edwards JR, Cohen J, Bamberg WM, Clark LA, Farley MM, Johnston H, Nadle J, Winston L, Gerding DN, McDonald LC, Lessa FC; Clostridium difficile Infection Surveillance Investigators, Centers for Disease Control and Prevention.

Clin Infect Dis. 2013 Nov;57(9):1304-7. doi: 10.1093/cid/cit492. Epub 2013 Jul 29.

PMID:
23899677
46.

Editorial Commentary: looking to the future: vertical vs horizontal prevention of Clostridium difficile infections.

McDonald LC.

Clin Infect Dis. 2013 Oct;57(8):1103-5. doi: 10.1093/cid/cit477. Epub 2013 Jul 23. No abstract available.

47.

Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011.

Chitnis AS, Holzbauer SM, Belflower RM, Winston LG, Bamberg WM, Lyons C, Farley MM, Dumyati GK, Wilson LE, Beldavs ZG, Dunn JR, Gould LH, MacCannell DR, Gerding DN, McDonald LC, Lessa FC.

JAMA Intern Med. 2013 Jul 22;173(14):1359-67. doi: 10.1001/jamainternmed.2013.7056.

PMID:
23780507
48.

Attributable burden of hospital-onset Clostridium difficile infection: a propensity score matching study.

Tabak YP, Zilberberg MD, Johannes RS, Sun X, McDonald LC.

Infect Control Hosp Epidemiol. 2013 Jun;34(6):588-96. doi: 10.1086/670621. Epub 2013 Apr 19.

PMID:
23651889
49.

National estimates of central line-associated bloodstream infections in critical care patients.

Wise ME, Scott RD 2nd, Baggs JM, Edwards JR, Ellingson KD, Fridkin SK, McDonald LC, Jernigan JA.

Infect Control Hosp Epidemiol. 2013 Jun;34(6):547-54. doi: 10.1086/670629. Epub 2013 Apr 18.

50.

Assessment of public health perspectives on responding to an emerging pathogen: carbapenem-resistant Enterobacteriaceae.

Guh AY, McDonald LC, Sinkowitz-Cochran R.

J Public Health Manag Pract. 2013 Jul-Aug;19(4):E27-32. doi: 10.1097/PHH.0b013e3182703e1c.

Supplemental Content

Loading ...
Support Center